Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Depreciation and Depletion: 2020-2025

Historic Depreciation and Depletion for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $3.8 million.

  • Agilon Health's Depreciation and Depletion rose 2258.06% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 3162.39%. This contributed to the annual value of $12.2 million for FY2024, which is 5250.0% up from last year.
  • Agilon Health's Depreciation and Depletion amounted to $3.8 million in Q3 2025, which was up 2258.06% from $3.9 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Depreciation and Depletion registered a high of $3.9 million during Q2 2025, and its lowest value of $500000.0 during Q4 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $1.8 million (2023), whereas its average is $2.0 million.
  • As far as peak fluctuations go, Agilon Health's Depreciation and Depletion plummeted by 1666.67% in 2021, and later skyrocketed by 20000.0% in 2023.
  • Over the past 5 years, Agilon Health's Depreciation and Depletion (Quarter) stood at $500000.0 in 2021, then soared by 140.0% to $1.2 million in 2022, then soared by 100.0% to $2.4 million in 2023, then soared by 37.5% to $3.3 million in 2024, then grew by 15.15% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.9 million for Q2 2025, and $3.8 million during Q1 2025.